Literature DB >> 23164550

Amyloid imaging and cognitive decline in nondemented oldest-old: the 90+ Study.

Claudia H Kawas1, Dana E Greenia, Szofia S Bullain, Christopher M Clark, Michael J Pontecorvo, Abhinay D Joshi, María M Corrada.   

Abstract

BACKGROUND: The goal of this study was to examine cross-sectional and longitudinal associations between cognitive performance and beta amyloid (Aβ) load determined by florbetapir F18 positron emission tomography (PET) in nondemented oldest-old.
METHODS: Thirteen nondemented (normal or cognitively impaired nondemented) participants (median age, 94.2 years) from The 90+ Study underwent florbetapir-PET scanning within 3 months of baseline neuropsychological testing. Amyloid load was measured with a semi-automated quantitative analysis of average cortical-to-cerebellar standardized uptake value ratio (SUVr) and a visual interpretation (Aβ- or Aβ+). Neuropsychological testing was repeated every 6 months.
RESULTS: At baseline, SUVr correlated significantly with tests of global cognition and memory. During follow-up (median, 1.5 years), the Aβ+ group had steeper declines on most cognitive tests, particularly global cognitive measures.
CONCLUSION: This preliminary study suggests that greater amyloid load is associated with poorer cognition and faster cognitive decline in nondemented oldest-old. Amyloid load may identify individuals at increased risk of developing Alzheimer's disease.
Copyright © 2013 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23164550      PMCID: PMC3604036          DOI: 10.1016/j.jalz.2012.06.005

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  10 in total

1.  Neuropsychological data in nondemented oldest old: the 90+ Study.

Authors:  Christina Whittle; Maria M Corrada; Malcolm Dick; Raphael Ziegler; Kristin Kahle-Wrobleski; Annlia Paganini-Hill; Claudia Kawas
Journal:  J Clin Exp Neuropsychol       Date:  2007-04       Impact factor: 2.475

2.  Dementia incidence continues to increase with age in the oldest old: the 90+ study.

Authors:  María M Corrada; Ron Brookmeyer; Annlia Paganini-Hill; Daniel Berlau; Claudia H Kawas
Journal:  Ann Neurol       Date:  2010-01       Impact factor: 10.422

3.  A population-based clinicopathological study in the oldest-old: the 90+ study.

Authors:  Maria M Corrada; Daniel J Berlau; Claudia H Kawas
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

Review 4.  Morphological substrates of cognitive decline in nonagenarians and centenarians: a new paradigm?

Authors:  Anouk Imhof; Enikö Kövari; Armin von Gunten; Gabriel Gold; Claire-Bénédicte Rivara; François R Herrmann; Patrick R Hof; Constantin Bouras; Panteleimon Giannakopoulos
Journal:  J Neurol Sci       Date:  2007-02-15       Impact factor: 3.181

5.  Use of florbetapir-PET for imaging beta-amyloid pathology.

Authors:  Christopher M Clark; Julie A Schneider; Barry J Bedell; Thomas G Beach; Warren B Bilker; Mark A Mintun; Michael J Pontecorvo; Franz Hefti; Alan P Carpenter; Matthew L Flitter; Michael J Krautkramer; Hank F Kung; R Edward Coleman; P Murali Doraiswamy; Adam S Fleisher; Marwan N Sabbagh; Carl H Sadowsky; Eric P Reiman; P Eric M Reiman; Simone P Zehntner; Daniel M Skovronsky
Journal:  JAMA       Date:  2011-01-19       Impact factor: 56.272

6.  Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.

Authors:  John C Morris; Catherine M Roe; Elizabeth A Grant; Denise Head; Martha Storandt; Alison M Goate; Anne M Fagan; David M Holtzman; Mark A Mintun
Journal:  Arch Neurol       Date:  2009-12

7.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

8.  Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Authors:  Kerryn E Pike; Greg Savage; Victor L Villemagne; Steven Ng; Simon A Moss; Paul Maruff; Chester A Mathis; William E Klunk; Colin L Masters; Christopher C Rowe
Journal:  Brain       Date:  2007-10-10       Impact factor: 13.501

9.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

10.  Age, neuropathology, and dementia.

Authors:  George M Savva; Stephen B Wharton; Paul G Ince; Gillian Forster; Fiona E Matthews; Carol Brayne
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

  10 in total
  24 in total

1.  Amyloid Positivity Using [18F]Flutemetamol-PET and Cognitive Deficits in Nondemented Community-Dwelling Older Adults.

Authors:  Dustin B Hammers; Taylor J Atkinson; Bonnie C A Dalley; Kayla R Suhrie; Kevin P Horn; Kelli M Rasmussen; Britney E Beardmore; Lance D Burrell; Kevin Duff; John M Hoffman
Journal:  Am J Alzheimers Dis Other Demen       Date:  2017-04-12       Impact factor: 2.035

2.  Neuroimaging markers associated with maintenance of optimal memory performance in late-life.

Authors:  Maria Dekhtyar; Kathryn V Papp; Rachel Buckley; Heidi I L Jacobs; Aaron P Schultz; Keith A Johnson; Reisa A Sperling; Dorene M Rentz
Journal:  Neuropsychologia       Date:  2017-05-01       Impact factor: 3.139

3.  The Future for Dementia Research: a Perspective from the Journal of Molecular Neuroscience.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2016-11       Impact factor: 3.444

Review 4.  The evolution of preclinical Alzheimer's disease: implications for prevention trials.

Authors:  Reisa Sperling; Elizabeth Mormino; Keith Johnson
Journal:  Neuron       Date:  2014-11-05       Impact factor: 17.173

5.  Low cortical iron and high entorhinal cortex volume promote cognitive functioning in the oldest-old.

Authors:  Jiri M G van Bergen; Xu Li; Frances C Quevenco; Anton F Gietl; Valerie Treyer; Sandra E Leh; Rafael Meyer; Alfred Buck; Philipp A Kaufmann; Roger M Nitsch; Peter C M van Zijl; Christoph Hock; Paul G Unschuld
Journal:  Neurobiol Aging       Date:  2017-12-20       Impact factor: 4.673

6.  Correlation between two methods of florbetapir PET quantitative analysis.

Authors:  Christopher Breault; Jonathan Piper; Abhinay D Joshi; Sara D Pirozzi; Aaron S Nelson; Ming Lu; Michael J Pontecorvo; Mark A Mintun; Michael D Devous
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-07-15

Review 7.  18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Authors:  Gabriel Martínez; Robin Wm Vernooij; Paulina Fuentes Padilla; Javier Zamora; Xavier Bonfill Cosp; Leon Flicker
Journal:  Cochrane Database Syst Rev       Date:  2017-11-22

8.  Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study.

Authors:  Lindsay R Clark; Annie M Racine; Rebecca L Koscik; Ozioma C Okonkwo; Corinne D Engelman; Cynthia M Carlsson; Sanjay Asthana; Barbara B Bendlin; Rick Chappell; Christopher R Nicholas; Howard A Rowley; Jennifer M Oh; Bruce P Hermann; Mark A Sager; Bradley T Christian; Sterling C Johnson
Journal:  Alzheimers Dement       Date:  2016-01-21       Impact factor: 21.566

Review 9.  Dementia in the oldest old.

Authors:  Zixuan Yang; Melissa J Slavin; Perminder S Sachdev
Journal:  Nat Rev Neurol       Date:  2013-06-04       Impact factor: 42.937

10.  Discrete Pools of Oligomeric Amyloid-β Track with Spatial Learning Deficits in a Mouse Model of Alzheimer Amyloidosis.

Authors:  Angie C A Chiang; Stephanie W Fowler; Rohit Reddy; Olga Pletnikova; Juan C Troncoso; Mathew A Sherman; Sylvain E Lesne; Joanna L Jankowsky
Journal:  Am J Pathol       Date:  2017-12-15       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.